PharmaShots | Incisive News in 3 Shots

Subscribe Now

Diabetic Kidney Disease

Janssen Collaborates with Vifor Pharma to Co-commercialize Invokana (canagliflozin) for the Treatment of Diabetic Kidney Disease in the US

Janssen Collaborates with Vifor Pharma to Co-commercialize Invokana (canagliflozin) for the Treatment of Diabetic Kidney Disease i...

November 4, 2019

Janssen's Invokana (canagliflozin) Receives the US FDA's Approval for Patients with Type 2 Diabetes and Diabetic Kidney Disease

Janssen's Invokana (canagliflozin) Receives the US FDA's Approval for Patients with Type 2 Diabetes and Diabetic Kidney Disease

October 1, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us